Article
Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways.
Pharmaceutical research - 1 Oct 2008
Rodrigues-Díez Raquel, Carvajal-González Gisselle, Sánchez-López Elsa, Rodríguez-Vita Juan, Rodrigues Díez Raúl, Selgas Rafael, Ortiz Alberto, Egido Jesús, Mezzano Sergio, Ruiz-Ortega Marta
Abstract excerpt
PURPOSE: Tubulointerstitial fibrosis is a final common pathway to end-stage chronic kidney diseases, which are characterized by elevated renal angiotensin II (AngII) production. This peptide participates in kidney damage inducing fibrosis and epithelial mesenchymal transition (EMT). Our aim was to describe potential therapeutic targets in AngII-induced EMT, investigating the blockade of different intracellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
